{
    "organizations": [],
    "uuid": "bc3eb88d8c0dc6f92640c1b85bf3ed92bd352c4b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-co-don-successful-conclusion-of-ph/brief-co-don-successful-conclusion-of-phase-ii-trial-co-dis-idUSFWN1RI04M",
    "ord_in_thread": 0,
    "title": "BRIEF-CO DON: Successful Conclusion Of Phase II Trial 'co.dis'",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Co Don AG:\n* CONCLUSION OF PHASE II TRIAL ‘CO.DIS’ DEMONSTRATES EFFICACY AND SAFETY OF EU-AUTHORISED PHARMACEUTICAL PRODUCT SPHEROX Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T17:43:00.000+03:00",
    "crawled": "2018-04-06T21:44:17.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "co",
        "ag",
        "conclusion",
        "phase",
        "ii",
        "trial",
        "demonstrates",
        "efficacy",
        "safety",
        "pharmaceutical",
        "product",
        "spherox",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}